In another randomized clinical trial consisting of 130 COVID-19 patients with hypovitaminosis D, high dose (60,000 IU) daily oral supplementation of Vitamin D significantly increased systemic Vitamin D levels and decreased the levels of the following inflammatory markers: C-reactive peptide (CRP), IL-6, and Neutrophil/lymphocyte ratio (75). Here, CRP is linked to COVID-19.